NR3C1 and breast carcinoma: Clinically, synthetic glucocorticoids (GR agonists) such as dexamethasone are ubiquitously used in breast cancer in conjunction with chemotherapy to mitigate hypersensitivity reactions, and for their antiemetic, anti-inflammatory, as well as orexigenic properties.